Middle East And Africa Botulinum Toxin Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	100 Pages	Triton Market Research	August, 2023	TRTN18135578

Best Price Guarantee
Price	from $1,500
Length	100 Pages
Publisher	Triton Market Research
Published Date	August, 2023
SKU	TRTN18135578

Middle East And Africa Botulinum Toxin Market 2023-2030

Market Outlook

Triton Market Research’s report states that the botulinum toxin market in the Middle East and Africa is predicted to advance in value at a compound annual growth rate of 10.03% during the forecast years 2023-2030. Israel, South Africa, the UAE, Saudi Arabia, and Rest of Middle East & Africa are taken into consideration in the reviewed region.

Botox has emerged as the most favored aesthetic treatment, administered to the face for the purpose of minimizing the visibility of wrinkles in Israel. Estimates indicate around 290,000 individuals underwent Botox injections for cosmetic purposes in 2021. This count excludes those who received Botox injections to address diverse medical conditions such as persistent pain or allergy symptoms. The country presently hosts approximately 300 specialized doctors practicing plastic and aesthetic surgery. All these factors contribute to the botulinum toxin market’s growth across the country.

Furthermore, the growing purchasing power and preference for cosmetic treatments supplement the botulinum toxin market’s development in Saudi Arabia. The introduction of minimally invasive procedures has increased the treatment’s demand among middle-aged women for aesthetic purposes. Besides this, the consumer-driven investment value of cosmetic treatments plays a key role in the nation’s economic diversification.
Competitive Outlook
Some of the widely known companies in the botulinum toxin market include AbbVie Inc, Evolus Inc, Medytox Inc, Lanzhou Institute of Biological Products Co Ltd, and Daewoong Pharmaceutical Co Ltd.

1. Middle East And Africa Botulinum Toxin Market - Summary
2. Industry Outlook: 2.1. Impact Analysis On The Botulinum Toxin Market; 2.1.1. Covid-19 Impact; 2.2. Key Insights; 2.2.1. Growing Demand For Non-invasive Cosmetic Procedures; 2.2.2. Surge In Demand For Botulinum Toxin Among Millennials And Gen-z; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Regulatory Framework; 2.5. Key Market Strategies; 2.5.1. Product Launches; 2.5.2. Collaborations; 2.5.3. Business Expansions & Divestitures; 2.5.4. Acquisitions; 2.6. Market Drivers; 2.6.1. Surge In Demand For Aesthetic Procedures; 2.6.2. Rise In Geriatric Population; 2.7. Market Challenges; 2.7.1. Limited Reimbursement Policies Supporting Cosmetic Procedures; 2.7.2. Adverse Effects Of Botulinum Toxin; 2.7.3. Emerging Problem Of Botulinum Toxin Type A Resistance; 2.8. Market Opportunities; 2.8.1. Expansion Of Botulinum Toxin Into Therapeutic Applications; 2.8.2. Rising Medical Tourism; 2.9. Analyst Perspective
3. Middle East And Africa Botulinum Toxin Market Outlook - By Product Type: 3.1. Type A Botulinum Toxin; 3.2. Type B Botulinum Toxin
4. Middle East And Africa Botulinum Toxin Market Outlook - By Gender: 4.1. Women; 4.2. Men
5. Middle East And Africa Botulinum Toxin Market Outlook - By Application: 5.1. Aesthetic; 5.1.1. Crow’s Feet; 5.1.2. Forehead Lines; 5.1.3. Frown Lines/Glabellar; 5.1.4. Square Jaw/Masseter; 5.1.5. Other Aesthetic Applications; 5.2. Medical; 5.2.1. Chronic Migraine; 5.2.2. Muscle Spasm; 5.2.3. Overactive Bladder; 5.2.4. Hyperhidrosis; 5.2.5. Other Medical Applications
6. Middle East And Africa Botulinum Toxin Market Outlook - By End-user: 6.1. Specialty And Dermatology Clinics; 6.2. Hospitals And Clinics; 6.3. Other End-users
7. Middle East And Africa Botulinum Toxin Market – By Country Outlook: 7.1. Middle East And Africa; 7.1.1. Market By Product Type; 7.1.2. Market By Gender; 7.1.3. Market By Application; 7.1.3.1. Market By Aesthetic; 7.1.3.2. Market By Medical; 7.1.4. Market By End-user; 7.1.5. Country Analysis; 7.1.5.1. United Arab Emirates; 7.1.5.1.1. United Arab Emirates Botulinum Toxin Market Forecast & Prospects; 7.1.5.2. Saudi Arabia; 7.1.5.2.1. Saudi Arabia Botulinum Toxin Market Forecast & Prospects; 7.1.5.3. Israel; 7.1.5.3.1. Israel Botulinum Toxin Market Forecast & Prospects; 7.1.5.4. South Africa; 7.1.5.4.1. South Africa Botulinum Toxin Market Forecast & Prospects; 7.1.5.5. Rest Of Middle East & Africa; 7.1.5.5.1. Rest Of Middle East & Africa Botulinum Toxin Market Forecast & Prospects
8. Competitive Landscape: 8.1. Abbvie Inc; 8.1.1. Overview; 8.1.2. Product Portfolio; 8.1.3. Key Strengths; 8.1.4. Key Challenges; 8.2. Evolus Inc; 8.2.1. Overview; 8.2.2. Product Portfolio; 8.2.3. Key Strengths; 8.2.4. Key Challenges; 8.3. Medytox Inc; 8.3.1. Overview; 8.3.2. Product Portfolio; 8.3.3. Key Strengths; 8.3.4. Key Challenges; 8.4. Lanzhou Institute Of Biological Products Co Ltd; 8.4.1. Overview; 8.4.2. Product Portfolio; 8.4.3. Key Strengths; 8.4.4. Key Challenges; 8.5. Daewoong Pharmaceutical Co Ltd; 8.5.1. Overview; 8.5.2. Product Portfolio; 8.5.3. Key Strengths; 8.5.4. Key Challenges; 8.6. Galderma Sa; 8.6.1. Overview; 8.6.2. Product Portfolio; 8.6.3. Key Strengths; 8.6.4. Key Challenges; 8.7. Ipsen Pharma; 8.7.1. Overview; 8.7.2. Product Portfolio; 8.7.3. Key Strengths; 8.7.4. Key Challenges; 8.8. Hugel Inc; 8.8.1. Overview; 8.8.2. Product Portfolio; 8.8.3. Key Strengths; 8.8.4. Key Challenges; 8.9. Candela Medical Corporation; 8.9.1. Overview; 8.9.2. Product Portfolio; 8.9.3. Key Strengths; 8.9.4. Key Challenges; 8.10. Merz Pharma Gmbh & Co Kgaa; 8.10.1. Overview; 8.10.2. Product Portfolio; 8.10.3. Key Strengths; 8.10.4. Key Challenges; 8.11. Revance Therapeutics Inc; 8.11.1. Overview; 8.11.2. Product Portfolio; 8.12. Us Worldmeds Llc; 8.12.1. Overview; 8.12.2. Product Portfolio
9. Research Methodology & Scope: 9.1. Research Scope & Deliverables; 9.2. Sources Of Data; 9.3. Research Methodology
List Of Tables: Table 1: Middle East And Africa Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million); Table 2: Middle East And Africa Regulatory Framework For Botulinum Toxin; Table 3: List Of Product Launches; Table 4: List Of Collaborations; Table 5: List Of Business Expansions & Divestitures; Table 6: List Of Acquisitions; Table 7: Example Of Commercially Available Botulinum Toxin Type A For Aesthetic Procedures; Table 8: Middle East And Africa Botulinum Toxin Market, By Product Type, 2023-2030 (In $ Million); Table 9: Middle East And Africa Botulinum Toxin Market, By Gender, 2023-2030 (In $ Million); Table 10: Middle East And Africa Botulinum Toxin Market, By Application, 2023-2030 (In $ Million); Table 11: Middle East And Africa Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Table 12: Middle East And Africa Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Table 13: Middle East And Africa Botulinum Toxin Market, By End-user, 2023-2030 (In $ Million); Table 14: Middle East And Africa Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million)
List Of Figures: Figure 1: Middle East And Africa Botulinum Toxin Market, By Product Type, 2022 & 2030 (In %); Figure 2: Middle East And Africa Botulinum Toxin Market, By Type A Botulinum Toxin, 2023-2030 (In $ Million); Figure 3: Middle East And Africa Botulinum Toxin Market, By Type B Botulinum Toxin, 2023-2030 (In $ Million); Figure 4: Middle East And Africa Botulinum Toxin Market, By Gender, 2022 & 2030 (In %); Figure 5: Middle East And Africa Botulinum Toxin Market, By Women, 2023-2030 (In $ Million); Figure 6: Middle East And Africa Botulinum Toxin Market, By Men, 2023-2030 (In $ Million); Figure 7: Middle East And Africa Botulinum Toxin Market, By Application, 2022 & 2030 (In %); Figure 8: Middle East And Africa Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Figure 9: Middle East And Africa Botulinum Toxin Market, By Aesthetic, 2022 & 2030 (In %); Figure 10: Middle East And Africa Botulinum Toxin Market, By Crow’s Feet, 2023-2030 (In $ Million); Figure 11: Middle East And Africa Botulinum Toxin Market, By Forehead Lines, 2023-2030 (In $ Million); Figure 12: Middle East And Africa Botulinum Toxin Market, By Frown Lines/Glabellar, 2023-2030 (In $ Million); Figure 13: Middle East And Africa Botulinum Toxin Market, By Square Jaw/Masseter, 2023-2030 (In $ Million); Figure 14: Middle East And Africa Botulinum Toxin Market, By Other Aesthetic Applications, 2023-2030 (In $ Million); Figure 15: Middle East And Africa Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Figure 16: Middle East And Africa Botulinum Toxin Market, By Medical, 2022 & 2030 (In %); Figure 17: Middle East And Africa Botulinum Toxin Market, By Chronic Migraine, 2023-2030 (In $ Million); Figure 18: Middle East And Africa Botulinum Toxin Market, By Muscle Spasm, 2023-2030 (In $ Million); Figure 19: Middle East And Africa Botulinum Toxin Market, By Overactive Bladder, 2023-2030 (In $ Million); Figure 20: Middle East And Africa Botulinum Toxin Market, By Hyperhidrosis, 2023-2030 (In $ Million); Figure 21: Middle East And Africa Botulinum Toxin Market, By Other Medical Applications, 2023-2030 (In $ Million); Figure 22: Middle East And Africa Botulinum Toxin Market, By End-user, 2022 & 2030 (In %); Figure 23: Middle East And Africa Botulinum Toxin Market, By Specialty And Dermatology Clinics, 2023-2030 (In $ Million); Figure 24: Middle East And Africa Botulinum Toxin Market, By Hospitals And Clinics, 2023-2030 (In $ Million); Figure 25: Middle East And Africa Botulinum Toxin Market, By Other End-users, 2023-2030 (In $ Million); Figure 26: Middle East And Africa Botulinum Toxin Market, By Country Outlook, 2022 & 2030 (In %); Figure 27: United Arab Emirates Botulinum Toxin Market 2023-2030 (In $ Million); Figure 28: Saudi Arabia Botulinum Toxin Market 2023-2030 (In $ Million); Figure 29: Israel Botulinum Toxin Market 2023-2030 (In $ Million); Figure 30: South Africa Botulinum Toxin Market 2023-2030 (In $ Million); Figure 31: Rest Of Middle East & Africa Botulinum Toxin Market 2023-2030 (In $ Million)